neffy® nasal spray– emergency epi without a needle
Description
Summary: neffy® nasal spray received fast track approval from the FDA on August 9, 2024 for the emergency treatment of type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weight at least 66 pounds. This may be a gamechanger in that it provides emergency epinephrine treatment for anaphylaxis without needles. But, as with all medications, correct use and monitoring is necessary.
Topics
· Fast Track Approval 01:30
· $$$ 03:15
· Minimum Weight 66 pounds 04:15
· Approval Process 06:00
· Pharmacokinetics & Pharmacodynamics 07:00
· Epi Mechanism of Action 08:00
· How to use neffy 10:45
· Storage 13:00
· Gamechanger? 15:00
· risk – BENEFIT 16:20
· Dosing (1/2 Life) 18:25
· Storage 22:15
Questions and comments to druggistforthepeople@gmail.com
United States
